ClinicalTrials.gg
Not yet recruitingNCT07706621Updated Jul 16, 2026

Pilot Trial of Robotic Hand Therapy After Stroke

An interventional study of robotic-assisted hand therapy and Action-observation therapy & Education in Stroke, sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-16.

Sponsored by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 444 studies in Stroke with a site in Canada — 83 open to participants now, 99 under way, 13 of them phase 3. Stroke · Canada.

Planned enrollment
306th of 374
20 · median 74
Started
2026
with 20 others
No phase
224 of 444
50 open now
Primary completion
2027-07
later than 51 of 98 live
Registered
441st of 444
by date

Among the 444 studies in Stroke with a site in Canada, this one is the 306th largest by planned enrollment of the 374 interventional ones that give a count, is one of 21 that started in 2026, is one of 224 with no phase, reaches primary completion later than 51 of the 98 other live ones, and was the 441st registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

83 of the 444 studies in Stroke with a site in Canada are open now. Recruiting first, the newest first:

78 more — sign in →

All 83 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 444 studies in Stroke with a site in Canada, or all of them as a file.
02

Study summary

This pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. About 20 participants will be randomly assigned to either the GRIP program or action-observation therapy with education, in addition to usual care. The study will assess motor improvement, safety, and acceptability over approximately six weeks.

Read the detailed description

The goal of this pilot clinical trial is to determine whether the Glove for Rehabilitation and Interactive Practice (GRIP) program can help improve hand and arm movement in adults who have difficulty using their hand after a recent stroke. The GRIP program uses a soft robotic glove and a virtual reality training platform. It is added to the usual rehabilitation care that participants already receive.

The main questions this study aims to answer are:

  • Does the GRIP program help improve hand and arm movement?
  • Is the GRIP program safe?
  • Do participants find the GRIP program acceptable, comfortable, and engaging? (qualitatively).

Researchers will compare the Glove for Rehabilitation and Interactive Practice (GRIP) program with action-observation therapy and education. Action-observation therapy means watching videos of hand movements and then practicing the same movements. Both groups will also receive their usual rehabilitation care. This study will include about 20 adults who are in an inpatient rehabilitation program after a stroke and who have difficulty using their hand.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • stroke
  • cerebrovascular accident
  • virtual reality
  • virtual environment
  • robotics
  • exosqueleton
  • finger
  • hand
  • grasp
  • manual dexterity
  • prehension
  • upper limb
  • motor recovery
  • subacute
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • First unilateral stroke (\<6-month post-stroke at enrollment)
  • ≥18 years old
  • Hand sensorimotor impairments
  • Able to understand and follow a two-step instruction
  • Admitted to the rehabilitation center and participating in the stroke program

Exclusion criteria

Exclusion Criteria:

  • Severe spasticity (score ≥3 on the Modified Ashworth Scale)
  • Unilateral spatial neglect
  • Moderate to severe hand pain
  • Significant motor impairment of the fingers (active finger flexion/extension less than 10°)
  • Any medical condition that may interfere with participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Glove for Rehabilitation and Interactive Practice (GRIP) program

    10 participants will be randomly assigned to this group.

    Device: robotic-assisted hand therapy

  • Active comparator
    Action-Observation Therapy (AOT) and Education

    10 participants will be randomly assigned to this group.

    Behavioral: Action-observation therapy & Education

Interventions

  • Devicerobotic-assisted hand therapy

    Participants will receive the GRIP program in addition to usual rehabilitation care. The program uses a soft robotic glove worn on the affected hand together with a non-immersive virtual-reality system that displays hand exercises and a virtual hand that moves with the participant's real movements. The glove can provide assistance or resistance to support grasping practice and strengthening. Training focuses on repeated grasping tasks and strategies to increase use of the affected hand in daily activities. The program includes ten supervised 30-minute sessions over two weeks.

    Also known as: hand exosqueleton coupled with a virtual reality program

  • BehavioralAction-observation therapy & Education

    Participants will receive usual rehabilitation care plus action-observation therapy (AOT). They will complete ten self-directed 30-minute AOT sessions over two weeks. Each session consists of repeated cycles of watching short videos of hand movements and then attempting to reproduce those movements with the affected hand. Videos will match the grasp types practiced in the intervention arm. Participants will also attend three individual education sessions on post-stroke arm and hand recovery, including strategies to increase use of the affected hand in daily activities.

    Also known as: Education, Action-Observation Therapy

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Assessment Upper Extremity (FMA-UE)

    It is a stroke-specific, performance-based impairment index designed to measure upper extremity motor recovery after stroke.

    Time frame: At enrollment , post-intervention (at 2 weeks), and 1 month follow-up (at 6 weeks)

Secondary outcomes

  1. Action Research Arm Test

    Observational measure that examines upper limb functional recovery

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

Other outcomes

  1. Box and Blocks

    Unilateral gross manual dexterity

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

  2. Nine-Hole Peg Test

    Fine manual dexterity

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

  3. ABILHAND questionnaire

    Semi-structured item-response questionnaire that measures manual ability according to an individual's perceived difficulty performing daily bimanual tasks.

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

  4. Hand dynamometer

    Grip strength measurement

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow up (at 6 weeks)

  5. Pinch gauge

    To measure 2-finger pinch, 3-finger pinch and lateral pinch

    Time frame: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

  6. Semi-structured interview with the GRIP group

    A qualitative semi-structured interview on the satisfaction with the intervention, perceived benefits, tolerance and engagement

    Time frame: Post-intervention (at 2 weeks).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Jul 2027, 11 months later.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 11 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 9, 2026
First posted
Jul 16, 2026
StartEst.
Aug 1, 2026
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2027
Last update
Jul 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07706621
Lead sponsor
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal
Collaborators
National Research Council, Canada
Responsible party
Johanne Higgins (Researcher and Professor (School of rehabilitation, Université de Montréal), Université de Montréal) — Principal investigator
First posted
Jul 16, 2026
Start date
Aug 1, 2026 (estimated)
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Jul 16, 2026

Study contacts

Johanne Higgins, PhD
Contact
johanne.higgins@umontreal.ca
514 343-6111 ext. 29924
Marika Demers, PhD
Contact
marika.demers@umontreal.ca
514 343-6111 ext. 30897
Johanne Higgins, PhD
study director · Université de Montréal, CRIR
Marika Demers, PhD
study director · Université de Montréal, CRIR

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion